Understanding the Claudin-Low Subtype of Breast Cancer
Author Information
Author(s): Prat Aleix, Parker Joel S, Karginova Olga, Fan Cheng, Livasy Chad, Herschkowitz Jason I, He Xiaping, Perou Charles M
Primary Institution: University of North Carolina
Hypothesis
The study aims to comprehensively characterize the claudin-low intrinsic subtype of breast cancer.
Conclusion
Claudin-low tumors exhibit unique biological features and a poor prognosis, resembling mammary stem cells.
Supporting Evidence
- Claudin-low tumors are characterized by low expression of luminal differentiation markers.
- They show high enrichment for epithelial-to-mesenchymal transition markers.
- The majority of claudin-low tumors are triple-negative invasive ductal carcinomas.
- Claudin-low tumors have a response rate to chemotherapy that is intermediate between basal-like and luminal tumors.
- A differentiation hierarchy exists across all breast cancers, with claudin-low tumors resembling mammary epithelial stem cells.
Takeaway
Some types of breast cancer, called claudin-low tumors, are different from others and are harder to treat because they act like stem cells.
Methodology
The study compared clinical, pathological, and biological features of claudin-low tumors using a human tumor database and various data sets.
Potential Biases
Potential bias due to the reliance on existing databases and the classification of tumors based on gene expression.
Limitations
The study may not account for the influence of non-epithelial cells in tumor samples.
Participant Demographics
The study included a diverse group of breast cancer patients, but specific demographic details are not provided.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website